Ae. Lambert

736 total citations
35 papers, 599 citations indexed

About

Ae. Lambert is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Ae. Lambert has authored 35 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 9 papers in Genetics. Recurrent topics in Ae. Lambert's work include Diabetes Management and Research (17 papers), Pancreatic function and diabetes (12 papers) and Diabetes Treatment and Management (11 papers). Ae. Lambert is often cited by papers focused on Diabetes Management and Research (17 papers), Pancreatic function and diabetes (12 papers) and Diabetes Treatment and Management (11 papers). Ae. Lambert collaborates with scholars based in Belgium, Switzerland and India. Ae. Lambert's co-authors include Jean‐Marie Ketelslegers, Martin Buysschaert, Charles T. Stier, Benigna Blondel, Lelio Orci, Albert E. Renold, Yasunori Kanazawa, J. J. Hoet, Myriam Nenquin and Jean‐Claude Henquin and has published in prestigious journals such as Diabetes Care, Diabetes and FEBS Letters.

In The Last Decade

Ae. Lambert

32 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ae. Lambert Belgium 12 311 292 173 145 73 35 599
J. L. Ruse Canada 11 475 1.5× 283 1.0× 183 1.1× 56 0.4× 45 0.6× 22 748
A. E. Pontiroli Italy 14 267 0.9× 122 0.4× 97 0.6× 68 0.5× 122 1.7× 30 549
Ilan Irony United States 11 613 2.0× 301 1.0× 160 0.9× 78 0.5× 34 0.5× 18 859
Jean‐Claude Daubresse Belgium 10 195 0.6× 142 0.5× 101 0.6× 121 0.8× 63 0.9× 18 411
Stephen E. Dippe United States 11 356 1.1× 210 0.7× 113 0.7× 95 0.7× 131 1.8× 13 668
Gerlies Bock United States 12 626 2.0× 309 1.1× 234 1.4× 129 0.9× 167 2.3× 18 920
Sidney L. Dale United States 17 753 2.4× 215 0.7× 186 1.1× 79 0.5× 58 0.8× 32 922
I. Charles Sand United States 7 211 0.7× 58 0.2× 152 0.9× 46 0.3× 60 0.8× 9 460
Conn Jw United States 14 331 1.1× 201 0.7× 136 0.8× 24 0.2× 72 1.0× 28 607
R. Philip Eaton United States 11 235 0.8× 112 0.4× 108 0.6× 59 0.4× 152 2.1× 30 489

Countries citing papers authored by Ae. Lambert

Since Specialization
Citations

This map shows the geographic impact of Ae. Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ae. Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ae. Lambert more than expected).

Fields of papers citing papers by Ae. Lambert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ae. Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ae. Lambert. The network helps show where Ae. Lambert may publish in the future.

Co-authorship network of co-authors of Ae. Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of Ae. Lambert. A scholar is included among the top collaborators of Ae. Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ae. Lambert. Ae. Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lévêque, Philippe, et al.. (1991). Spontaneous Pituitary Apoplexy with Transient Panhypopituitarism and Diabetes Insipidus. Acta Clinica Belgica. 46(1). 30–36. 3 indexed citations
2.
Brichard, S. & Ae. Lambert. (1990). Perindopril Safety and Tolerance in At-Risk Patients. Drugs. 39(Supplement 1). 64–70. 2 indexed citations
3.
Brichard, S. M., et al.. (1990). Home blood glucose monitoring, glycosylated hemoglobin and fructosamine: their relationships in diabetic patients with and without residual C-peptide secretion.. PubMed. 15(6). 388–93. 7 indexed citations
4.
Brichard, S., et al.. (1990). Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.. PubMed. 16(1). 30–6. 12 indexed citations
5.
Ketelslegers, J M, et al.. (1990). [Diabetes, malnutrition and growth retardation].. PubMed. 145(1-2). 132–41; discussion 141. 1 indexed citations
6.
Jacques, Danielle, et al.. (1989). Effect of Computer-Assisted Insulin Delivery on Glycemic Control of Type i Diabetic Patients • A Preliminary Experience. Acta Clinica Belgica. 44(3). 169–173. 2 indexed citations
7.
Lambert, Ae., et al.. (1988). Effect of the addition of simple sugars to mixed meals on the glycemic control of insulin treated diabetic patients.. PubMed. 13(6). 625–9. 7 indexed citations
8.
Buysschaert, Martin, et al.. (1988). Metabolic and psychological evolution of insulin dependent diabetic patients during a 6 months insulin-pen treatment.. PubMed. 14(2). 75–9. 6 indexed citations
9.
Ketelslegers, Jean‐Marie, et al.. (1987). Serum fructosamine level as a marker of glycemic control in diabetic patients with and without a residual C-peptide secretion.. PubMed. 6(3). 129–31. 2 indexed citations
10.
Lambert, Ae.. (1987). Diagnosis and Treatment of Diabetic Coma. Acta Clinica Belgica. 42(4). 293–297. 6 indexed citations
11.
Ketelslegers, Jean‐Marie, et al.. (1986). Effect of glibenclamide in insulin-treated diabetic patients with a residual insulin secretion.. PubMed. 12(1). 34–8. 15 indexed citations
12.
Marchand, Étienne, Martin Buysschaert, Florin Grigorescu, et al.. (1983). The Hypoglycemic Effect of a Sulfonylurea (gliclazide) in Moderate Type-ii Diabetes and Glucose-intolerance Is Not Accompanied By Changes in Insulin Action and Insulin Binding To Erythrocytes. DIAL (Catholic University of Leuven). 4(1). 83–93. 5 indexed citations
13.
Buysschaert, Martin, et al.. (1983). Comparison of Plasma Glucose and Plasma Free Insulin During CSII and Intensified Conventional Insulin Therapy. Diabetes Care. 6(1). 1–5. 15 indexed citations
14.
Vandeleene, Bernard, Jean‐Marie Ketelslegers, & Ae. Lambert. (1982). Short-term Comparison of the Activities of Semi-synthetic Human Insulin and Monocomponent Porcine Insulin in Type-1 (insulin-dependent) Diabetics. DIAL (Catholic University of Leuven). 23(2). 207–207.
15.
Buysschaert, Martin, Étienne Marchand, Florin Grigorescu, et al.. (1982). Effect of Gliclazide On Insulin Effectiveness and Insulin Binding To Erythrocytes in Type-2 (non-insulin-dependent) Diabetic-patients. Digital Access to Libraries. 23(2). 159–159. 1 indexed citations
16.
Stier, Charles T., Jean‐Marie Ketelslegers, Martin Buysschaert, & Ae. Lambert. (1981). Hyperglycaemic effect of nifedipine.. BMJ. 283(6283). 19–20. 112 indexed citations
17.
Lambotte, Luc, Martin Buysschaert, Marc Reynaert, et al.. (1979). Surgical Application of An Artificial Pancreas. British journal of surgery. 66(12). 895–895. 3 indexed citations
18.
Lambert, Ae., J. C. Henquin, & Lorenzo A. Orci. (1972). Chlorpromazine in malignant insulinoma.. BMJ. 3(5828). 701.2–701. 10 indexed citations
19.
Lambert, Ae., Benigna Blondel, Yasunori Kanazawa, Lelio Orci, & Albert E. Renold. (1972). Monolayer Cell Culture of Neonatal Rat Pancreas: Light Microscopy and Evidence for Immunoreactive Insulin Synthesis and Release. Endocrinology. 90(1). 239–248. 84 indexed citations
20.
Lambert, Ae., et al.. (1971). Stimulation of Insulin Release in Vitro by Non-metabolized Amino Acid Analogues. Experimental Biology and Medicine. 137(2). 377–381. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026